Form EFFECT Biodexa Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 9, 2025 |
| Accession Number: | 0001214659-25-006581 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zoomlion Expands Mining Machinery Business as International Revenue Grows
- Cryptocurrency News: CFTC Drafts Its First Federal Trading Rules as Pepeto Eyes 100x Gains Over Cardano
- Azure IAM Expands Identity Integration Services Ahead of FedRAMP Deadline
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share